Clinical trial
The VAX-MOM Study: Increasing Influenza and Tdap Vaccination of Pregnant Women
NCT04444518 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The VAX-MOM Study: Increasing Influenza and Tdap Vaccination of Pregnant Women
- Lead sponsor
- University of Rochester
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2019
- Completion date
- June 30, 2022
- Enrollment
- 12,760 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immunization; infection, pregnancy related